Europe faces long wait for weight-loss drugs as governments eye costs

📆 7/10/2023 1:15 PM
📰 Reuters

⏱ Reading Time:
28 sec. here
2 min. at publisher
📊 Quality Score:
News: 14%
Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans will be able to get it.

A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File PhotoGermany bans 'lifestyle drug' coverage by public health plansEU obesity below U.S.

Germany's stance on weight-loss drugs is among the region's strictest, even though the proportion of its citizens who are overweight is above the European Union average. Martin Merkel, a medical professor and member of the German Endocrinology Society, said the drug offered a "very, very good opportunity" to reduce weight and prevent follow-on disease.

Novo boss Lars Fruergaard Jorgensen said in a newspaper interview on June 24 that the Danish company would launch the drug in Germany at the end of July.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Analysis: Europe faces long wait for weight-loss drugs as governments eye costsNovo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans will be able to get it.
Source: Reuters - 🏆 2. / 97 Read more »